Publication | Closed Access

Amniotic mesenchymal stem cells with robust chemotactic properties are effective in the treatment of a myocardial infarction model

Regenerative MedicineMechanobiologyMedicineAdult Stem CellRobust Chemotactic PropertiesEmbryonic Stem CellsStem-cell TherapyCell BiologyBiomedical EngineeringMesenchymal Stem CellMyocardial Infarction ModelStem CellsCell TransplantationEmbryonic Stem CellHealth Sciences